That the DEA has not rescheduled marijuana seems to go against all the scientific evidence and against a society that uses empirical evidence.MAPS executive director Rick Doblin said his organization, acting as a non-profit pharmaceutical company, had been trying for 22 years to develop Schedule I drugs like marijuana into FDA-approved medications, but that the DEA and other federal agencies had